Evidence map›Paper›PMID 29463531›Full record

ArticleAntimicrobial agents and chemotherapy2018

Complete Sequence of the IncA/C

Melina Ruggiero, Delphine Girlich, Laura Dabos, Pablo Power, Thierry Naas, Gabriel Gutkind

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Co-integrate Col3mMicrobiology spectrum · 2023
    Article
  2. Review
  3. A Multispecies Cluster of VIM-1 Carbapenemase-ProducingAntimicrobial agents and chemotherapy · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Melina RuggieroUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología y Biotecnología, Cátedra de Microbiología, Buenos Aires, Argentina.
Delphine GirlichEA7361, Université Paris-Sud, Université Paris-Saclay, LabEx LERMIT, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Laura DabosEA7361, Université Paris-Sud, Université Paris-Saclay, LabEx LERMIT, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Pablo PowerUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología y Biotecnología, Cátedra de Microbiología, Buenos Aires, Argentina.ORCID 0000-0002-7051-9954
Thierry NaasEA7361, Université Paris-Sud, Université Paris-Saclay, LabEx LERMIT, Bacteriology-Hygiene Unit, APHP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Gabriel GutkindUniversidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Departamento de Microbiología, Inmunología y Biotecnología, Cátedra de Microbiología, Buenos Aires, Argentina ggutkind@ffyb.uba.ar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCitrobacter freundiiDrug Resistance, Multiple, BacterialIntegronsMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsSequence Analysis, DNAAnti-Bacterial Agentsbeta-LactamasesIncA/Coxyimino-cephalosporinasePER-2pMLSTST13

Identifiers

PMID29463531
PMCPMC5923148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.